Clinical Trial Update: Safety Study of Sorafenib Following Combined Therapy of Radiation and TACE for Liver Cancer [Phase 1, Phase 2]

View source ↗

Summary

This document describes a Phase 1/Phase 2 safety study of Sorafenib used after combined radiation and transarterial chemoembolization (TACE) in hepatocellular c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Nexavar (Sorafenib)

Snippet

Sponsor: Fudan University | Conditions: Hepatocellular Carcinoma | Phase 1, Phase 2 | Status: UNKNOWN